Drugs / LEISH-F2
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00982774 | Apr 2009 → Apr 2011 | cutaneous leishmaniasis | Access to Advanced Health Institute (AAHI) | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01011309 | Oct 2009 → May 2011 | cutaneous leishmaniasis | Access to Advanced Health Institute (AAHI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LEISH-F2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01011309 ↗ |
| Modality | Protein / enzyme biologic | “LEISH-F2 protein” NCT00982774 ↗ |